This is the first study to report the differences in effect size of SUA associated genetic variants in SLC2A9 and ABCG2 in T2DM patients that suggests involvement of these gene variants in the alteration of uric acid levels in T2DM subjects. The gene discussed is ABCG2; the disease is type 2 diabetes mellitus.